EVIDENCE COMPARISON

Directional

Pimecrolimus
vs Metronidazole
for Redness Reduction

Early or indirect evidence suggests pimecrolimus may reduce redness 17% more effectively than metronidazole for improving skin tone, based on indirect comparison.

1.17x

Effect ratio

Pimecrolimus

Favored

2

Studies

Indirect

Comparison

ExploratorySubjective endpointTone

Limits: Indirect comparison · Includes subjective endpoint · Early-stage evidence tier

This is an indirect comparison — the two ingredients were not tested head-to-head in the same trial. The ratio is derived from separate studies against a common comparator.

How to read this claim

Kept public as exploratory because it indirect comparison; includes subjective endpoint; early-stage evidence tier.

Some study-specific context may affect how broadly this comparison generalizes.

Source Studies (2)

Metronidazole 0.75% gel vs. ketoconazole 2% cream in the treatment of facial seborrheic dermatitis: a randomized, double-blind study.

randomized, double-blind

An open, randomized, prospective, comparative study of topical pimecrolimus 1% cream and topical ketoconazole 2% cream in the treatment of seborrheic dermatitis.

randomized
Explore all comparisons →